profit from every SGD 100 of sales.
SGD 0SGD 100
IHH Healthcare Berhad
SGD 2.50+2.88% today
-5.7% in 1 year
1-year low SGD 2.361-year high SGD 3.07
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
0%20% a year
You pay SGD 34.29 for every SGD 1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
IHH Healthcare Berhad vs. similar companies
IHH Healthcare Berhad grows in the middle of these 5 and is priced in the middle for its profits.
| Company | Profit from SGD 100 of sales | Sales growth a year | Price per SGD 1 of profit |
|---|---|---|---|
| IHH Healthcare Berhad | 34.3× · Expensive | ||
 HCA Healthcare | 15.4× · Fair price | ||
 Fresenius SE & Co. KGaA | 23.9× · Fair price | ||
 Rede D'Or São Luiz | 16.2× · Fair price | ||
 Apollo Hospitals Enterprise | 63.1× · Very expensive |
AI analysis
An AI analyst reads IHH Healthcare Berhad's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisNo annual statements on file yet.
Valuation
- 34.3×
- –
- 3.23
- 0.8×
- 2.8×
- 38.0×
- –
- 2.6%
- 2.9%
- –
Profitability
- 71.7%
- 15.2%
- 8.2%
- –
- 8.0%
- 8.1%
- –
- –
- –
- –
Growth
- +12.7%
- +10.6%
- –
- –
- +0.1%
Financial health
- 2.2×
- 0.51
- –
- 4.4×
- 0.58
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 38%of 946
Top 35%of 872
Bottom 40%of 565
Top 45%of 867
Top 37%of 986
News
Gabelli Healthcare & Wellness Trust raises dividend by 17.6% to $0.20Seeking Alpha · Nov 11, 2026Healthcare Just Hit a Record Lead Over Tech. 3 Things Could Shrink ItYahoo Finance · Nov 11, 2026Notable healthcare headlines for the week: Moderna, Pfizer, and CVS Health in focusSeeking Alpha · Nov 8, 2026The Healthcare ETF Showdown: Broad Global Health or Targeted Pharma Power?Yahoo Finance · Nov 7, 2026American Healthcare REIT forecasts $2.23-$2.26 2026 NFFO per share as same-store NOI growth target rises to 12%-14%Seeking Alpha · Nov 6, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
48No pass
Benjamin Graham
56No pass
Philip Fisher
55No pass
Peter Lynch
32No pass
Joel Greenblatt
41No pass
Charlie Munger
36No pass
Terry Smith
36No pass
Questions about IHH Healthcare Berhad
Is IHH Healthcare Berhad a good stock to buy?
A solid business, but the price is high. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the IHH Healthcare Berhad AI analysis
What does IHH Healthcare Berhad do?
IHH Healthcare Berhad, an investment holding company, provides healthcare services in Singapore, Malaysia, India, Greater China, Japan, Türkiye and Europe, and internationally. It is in Medical Care Facilities.
Is IHH Healthcare Berhad stock halal?
Yes. IHH Healthcare Berhad passes our halal screen: its business is permitted and its debt is 22% of its market value, under the 30% limit. How we check
How has IHH Healthcare Berhad stock done over the past year?
Down 5.7% over the past twelve months, to SGD 2.50. It traded between SGD 2.36 and SGD 3.07 and is 18.6% below its high.
Who are IHH Healthcare Berhad's competitors?
The largest listed companies in the same industry are HCA Healthcare, Fresenius SE & Co. KGaA, Rede D'Or São Luiz and Apollo Hospitals Enterprise. The peers table on this page compares their profit, growth and price with IHH Healthcare Berhad's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.